Dr. John Klein
Provided by Sentara Northern Virginia Medical Center
Sentara Northern Virginia Medical Center announced today there is new hope for men who suffer from lower urinary tract symptoms (LUTS) as a result of benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. The new treatment, called Aquablation® therapy, is performed by the AQUABEAM System which uses a robot-controlled waterjet to remove the enlarged prostate tissue. It is the only FDA-cleared minimally invasive treatment for BPH that combines real-time, multi-dimensional imaging with surgical robotics and a heat-free waterjet for targeted, precise and safe removal of prostate tissue, with a reduced risk of sexual side effects.
Urologist John B. Klein, M.D., is one of the first doctors on the East Coast to offer this new treatment.
Until recently, with current BPH treatment options, men have had to choose between significant
symptom relief with a high risk of sexual side effects or a lower risk of sexual complications with less
symptomatic benefit. For this reason, many men have avoided treatment altogether. Aquablation
therapy eliminates the need for men to make the choice between symptom relief and risk.
Aquablation therapy with the AQUABEAM System is designed to break the tradeoff in BPH treatment
between efficacy and negative side effects, offering significant symptom improvement with a low risk
of sexual complications.
“With enlarged prostate or BPH, the symptoms cause fairly abrupt decrease in quality of life, people
can’t go to a movie without getting up twice to urinate, they can’t sleep through the night – that’s a big
thing. It’s one thing if you get up once and fall back asleep; it’s another if you get up three times and
you can’t get back to sleep afterwards or your wife can’t get back to sleep afterward. It’s a real
stressful thing,” said Dr. Klein of Potomac Urology, “We believe this therapy may fundamentally
transform the way we treat men with BPH.”
In the United States, there are over 12 million men being actively managed for their condition, of which two million have failed medical management and are looking for alternative treatment options.
